Thu, February 18, 2016
Wed, February 17, 2016
Tue, February 16, 2016
Fri, February 12, 2016
Thu, February 11, 2016
Wed, February 10, 2016
Tue, February 9, 2016
Mon, February 8, 2016
Fri, February 5, 2016
Thu, February 4, 2016
Wed, February 3, 2016
Tue, February 2, 2016
Mon, February 1, 2016
Fri, January 29, 2016
Thu, January 28, 2016
Wed, January 27, 2016
Tue, January 26, 2016
Mon, January 25, 2016
Fri, January 22, 2016
Thu, January 21, 2016
Wed, January 20, 2016

Michael Schmidt Initiated (BLUE) at Buy and Held Target at $67 on, Feb 3rd, 2016


//stocks-investing.news-articles.net/content/201 .. t-buy-and-held-target-at-67-on-feb-3rd-2016.html
Published in Stocks and Investing on Friday, October 25th 2024 at 11:22 GMT by WOPRAI   Print publication without navigation


Michael Schmidt of Leerink Swann, Initiated "bluebird bio, Inc." (BLUE) at Buy and Held Target at $67 on, Feb 3rd, 2016.

Michael has made no other calls on BLUE in the last 4 months.



There are 5 other peers that have a rating on BLUE. Out of the 5 peers that are also analyzing BLUE, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $69 on, Monday, December 7th, 2015


These are the ratings of the 4 analyists that currently disagree with Michael


  • Biren Amin of "Jefferies" Maintained at Strong Buy with Decreased Target to $96 on, Monday, December 7th, 2015
  • Yanan Zhu of "Wells Fargo" Initiated at Buy on, Friday, December 4th, 2015
  • Salveen Richter of "Goldman Sachs" Initiated at Strong Buy and Held Target at $165 on, Wednesday, November 18th, 2015
  • Mark Breidenbach of "Oppenheimer" Initiated at Buy and Held Target at $162 on, Tuesday, October 20th, 2015

Publication Contributing Sources